TY - JOUR
KW - Risk Index for Overdose or Serious Opioid-induced Respiratory Depression
KW - Prescription opioids
KW - Overdose
KW - respiratory depression
KW - screening risk index
KW - medical users
KW - test validation
KW - test refinement
KW - Empirical Study
KW - Longitudinal Study
KW - Retrospective Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - Young Adulthood (18-29 yrs)
KW - Thirties (30-39 yrs)
KW - Middle Age (40-64 yrs)
KW - Drug Overdoses
KW - Medical Patients
KW - Risk Assessment
KW - Risk Factors
KW - Drug Therapy
KW - Screening Tests
KW - Opiates
KW - Test Validity
KW - Index (Testing)
KW - Prescription Drugs
KW - Side Effects (Drug)
KW - Respiratory Distress
KW - article
KW - US
KW - 2226:Health Psychology Testing
KW - 3363:Medical Treatment of Physical Illness
AU - Barbara K. Zedler
AU - William B. Saunders
AU - Andrew R. Joyce
AU - Catherine C. Vick
AU - E. L. Murrelle
A1 - 
AD - Venebio Group, LLC, Richmond, VA, US barb.zedler@venebio.com; Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, NC, US ; Zedler, Barbara K.,7400 Beaufont Springs Drive, Suite 300,Richmond,US,23225,Venebio Group, LLC,barb.zedler@venebio.com
BT - Pain Medicine
C5 - Measures; Opioids & Substance Use
CP - 1
DO - 10.1093/pm/pnx009
IS - 1
JF - Pain Medicine
LA - English
M1 - Journal Article
PB - Oxford University Press Blackwell Publishing Wiley-Blackwell Publishing Ltd
PY - 2018
SN - 1526-2375, 1526-2375
SP - 68
EP - 78
EP - 
T1 - Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database
T2 - Pain Medicine
TI - Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database
U1 - Measures; Opioids & Substance Use
U3 - 10.1093/pm/pnx009
VL - 19
VO - 1526-2375, 1526-2375
Y1 - 2018
Y2 - 01
ER -